Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Haemonetics Corporation Common Stock (NY:HAE)

102.40 -1.12 (-1.08%)
Delayed Quote Updated: 2:41 PM EDT, Oct 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Haemonetics Corporation Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Mid-Day Market Update: Pfizer Sales Miss Expectations; Teradata Shares Spike Higher ↗
US stocks remained mostly higher on Tuesday, while the S&P 500 traded lower by 0.1%. 
Via Benzinga
News headline image
35 Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers Society Pass Incorporated (NASDAQ: SOPA) gained 63.4% to $3.45 after dropping 16% on Monday. American Rebel Holdings, Inc. (NASDAQ: AREB) climbed 56.1% to $3.45 following... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Pfizer, Amgen Shares Slip On Earnings, Editas Terminates Chief Medical Officer, Biogen Licenses Preclinical Rheumatoid Arthritis Biosimilar ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
Recap: Haemonetics Q3 Earnings ↗
  Haemonetics (NYSE:HAE) reported its Q3 earnings results on Tuesday, February 8, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight ↗
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,... 
Via Benzinga
News headline image
Earnings Scheduled For February 8, 2022 ↗
Companies Reporting Before The Bell • Pfizer (NYSE:PFE) is likely to report quarterly earnings at $0.87 per share on revenue of $24.20 billion. 
Via Benzinga
News headline image
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More ↗
Biotech stocks managed to close the week ending Feb. 4 with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid negative reaction to some big... 
Via Benzinga
News headline image
64 Biggest Movers From Yesterday ↗
Check out these penny stocks insiders are buying Losers ION Geophysical Corporation (NYSE: IO) shares fell 53.6% to settle at $0.51 on Thursday. Epizyme, Inc. (NASDAQ:... 
Via Benzinga
What 8 Analyst Ratings Have To Say About Haemonetics ↗
Analysts have provided the following ratings for Haemonetics (NYSE: 
Via Benzinga
News headline image
46 Stocks Moving In Thursday's Mid-Day Session ↗
Gainers Indonesia Energy Corporation Limited (NASDAQ: INDO) shares jumped 158.2% to $7.23 after tumbling 18% on Wednesday. Indonesia Energy said it projects to commence drilling... 
Via Benzinga
News headline image
75 Biggest Movers From Yesterday ↗
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep. Check out these big penny stock gainers and losers... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For January 27, 2022 ↗
Upgrades 
Via Benzinga
News headline image
Why Haemonetics Stock Dived by 15% Today ↗
The company broadly meets expectations for its Q2 2022 but trims its full-year guidance. 
Via The Motley Fool
News headline image
Haemonetics Corp (HAE) Q2 2022 Earnings Call Transcript ↗
HAE earnings call for the period ending October 2, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2021 ↗
Upgrades B of A Securities upgraded the previous rating for ONE Gas Inc (NYSE: 
Via Benzinga
News headline image
58 Stocks Moving In Monday's Mid-Day Session ↗
Gainers Dover Motorsports, Inc. (NYSE: DVD) shares climbed 60.3% to $3.59 after Speedway Motorsports announced it will acquire the company for $3.61 per share in cash. TDH... 
Via Benzinga
News headline image
Looking Into Haemonetics's Return On Capital Employed ↗
According to Benzinga Pro, during Q2, Haemonetics (NYSE:HAE) earned $24.51 million, a 398.43% increase from the preceding quarter. Haemonetics also posted a total of $239.90... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Gainers Compass Pathways (NASDAQ:CMPS) shares rose 18.43% to $51.0 during Tuesday's pre-market session. The company's market cap stands at $2.1 billion. As per the... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces... 
Via Benzinga
News headline image
Haemonetics' Vascade Vascular Closure Device Includes Same-Day Discharge Label ↗
Haemonetics Corp's (NYSE: HAE) Vascade MVP Venous Vascular Closure System becomes the first vascular closure device to receive FDA indication for same-day discharge... 
Via Benzinga
News headline image
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More ↗
Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out... 
Via Benzinga
News headline image
Looking into Haemonetics's Return on Capital Employed ↗
After pulling data from Benzinga Pro it seems like during Q1, Haemonetics (NYSE:HAE) posted sales of $228.53 million. Earnings were up 61.57%, but Haemonetics still reported an... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA Calendar Scaling The Peaks (Biotech Stocks... 
Via Benzinga
News headline image
Haemonetics Corp (HAE) Q1 2022 Earnings Call Transcript ↗
HAE earnings call for the period ending July 3, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10) Alnylam Pharmaceuticals,... 
Via Benzinga
News headline image
Recap: Haemonetics Q1 Earnings ↗
Shares of Haemonetics (NYSE:HAE) remained unaffected after the company reported Q1 results. Quarterly Results Earnings per share increased 8.70% year over year to $0.50,... 
Via Benzinga
News headline image
Cramer Gives His Opinion On Virgin Galactic, Zynex And More ↗
On CNBC's "Mad Money Lightning Round," Jim Cramer said Virgin Galactic Holdings Inc (NYSE: SPCE) is a very expensive stock. It had a nice run, but he would look for... 
Via Benzinga
News headline image
Why Haemonetics Stock Rallied on Friday ↗
One analyst upgrade in particular seemed to bring back the bulls. 
Via The Motley Fool
News headline image
What Does Haemonetics Debt Look Like? ↗
Shares of Haemonetics (NYSE:HAE) fell by 57.47% in the past three months. Before having a look at the importance of debt, let us look at how much debt Haemonetics has.... 
Via Benzinga
News headline image
A Look Into Haemonetics Price Over Earnings ↗
In the current market session, Haemonetics Inc. (NYSE:HAE) is trading at $56.67, after a 9.38% increase. However, over the past month, the stock fell by 51.55%, and... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.